The recently opened addition to the Chemistry Building on University Avenue is a nine-story tower housing lecture halls, an information commons, offices, teaching laboratories, and group write-up spaces for undergraduate teaching labs.
New research suggests that the peptides — short chunks of protein — used to treat Type 2 diabetes may be more effective if they’re able to flexibly move back and forth between different shapes.
New research findings from the UW, NOAA and others may change the way scientists predict how cloud formation responds to changes in the oceans.
On August 12, leaders from the Wisconsin Departments of Administration (DOA), Financial Institutions (DFI), and Safety & Professional Services (DSPS) toured several campus facilities to learn more about the ways UW strives to create solutions that address some of today’s biggest sustainability challenges.
UW–Madison will join a first-of-its-kind collaborative network for nuclear magnetic resonance spectroscopy, which researchers use to probe large biological molecules like proteins and RNA.
While the approach hasn’t yet been tested in humans and researchers must further refine and test the system, it does provide a new strategy for potentially preventing or treating these common infections.
The technology, developed by UW–Madison Professor Weiping Tang and colleagues in the School of Pharmacy, could produce entirely new kinds of drugs.
New research aims to measure the pancreas’s entire suite of proteins. Ultimately, that data will advance research on pancreatic diseases like pancreatitis, pancreatic cancer, or diabetes.
What's the difference between COVID-19 and influenza? What precautions should I take after potential buyers tour my home?
Physics professor Vernon Barger won the J.J. Sakurai Prize for Theoretical Particle Physics, and chemistry professor Martin Zanni was the recipient of the Earle K. Plyler Prize for Molecular Spectroscopy & Dynamics.
Coyle's research could have far-reaching applications, from expanding the scope of cell-based therapies to fight disease to developing micro-technologies for bioremediation of damaged environmental sites.
A wildly out-of-place protein leads to haywire cells in a particularly troublesome type of rare early childhood cancer, according to University of Wisconsin–Madison researchers.
The National Institutes of Health will provide $22.7 million over six years to create a national research and training hub at UW–Madison that will give scientists across the country access to this game-changing technology.
An effective test of cTnI variations could one day provide doctors with a better ability to diagnose heart disease, the leading cause of death in the U.S.